Patients with advanced EGFR-mutated NSCLC who were given osimertinib plus chemotherapy up front continue to show improved outcomes after initial progression, suggests ongoing trial data.
Within the framework of World Cancer Day, <a href="https://www.gob.pe/institucion/presidencia/funcionarios/77719-dina-ercilia-boluarte-zegarra"target=" blank"
Activities around Peru have included serving cancer patients, providing food to those in need, singing Christmas music and a torchlight parade in Callao, Cusco, Iquitos and Lima.